Tenofovir DF + Emtricitabine Tablets (300 mg + 200 mg)
Tenofovir DF + Emtricitabine is a fixed-dose combination of two nucleos(t)ide reverse transcriptase inhibitors (NRTIs) that forms a recommended backbone of antiretroviral regimens. The once-daily single-tablet format supports adherence across treatment and prophylaxis settings.
Indicated for the treatment of HIV-1 infection in combination with other antiretroviral agents in adults and adolescents, and for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at-risk adults and adolescents.
Disclaimer
The content on this website is for general informational purposes only. While we strive for accuracy, RV Group makes no warranties regarding the completeness, reliability, or suitability of the information. For detailed product specifications, regulatory documentation, or inquiries, please contact us directly.
Our Tenofovir DF + Emtricitabine Tablets (300 mg + 200 mg) are also Available for
FAQ on Tenofovir DF + Emtricitabine Tablets (300 mg + 200 mg)
Everything You Need to Know About RV Groups
RV Group operates through four integrated business verticals, each designed to create value across the pharmaceutical ecosystem.
Our Business
Quick Links
Contact
- hello@opv.vn
- +1 800 555 25 65